UY27731A1 - Utilización de antagonistas de ltb4 en medicina veterinaria - Google Patents

Utilización de antagonistas de ltb4 en medicina veterinaria

Info

Publication number
UY27731A1
UY27731A1 UY27731A UY27731A UY27731A1 UY 27731 A1 UY27731 A1 UY 27731A1 UY 27731 A UY27731 A UY 27731A UY 27731 A UY27731 A UY 27731A UY 27731 A1 UY27731 A1 UY 27731A1
Authority
UY
Uruguay
Prior art keywords
veterinary medicine
ltb4 antagonists
antagonists
ltb4
animals
Prior art date
Application number
UY27731A
Other languages
English (en)
Inventor
Dr Franz Birke
Kandace Matzek
Original Assignee
Boehringer Ingelheim Pharma
Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma, Co Kg filed Critical Boehringer Ingelheim Pharma
Publication of UY27731A1 publication Critical patent/UY27731A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El invento se refiere a la utilización de antagonistas de LTE4 para la preparación de un medicamento para el tratamiento o la prevención de enfermedades respiratorias en animales de companía y animales útiles.
UY27731A 2002-03-26 2003-03-24 Utilización de antagonistas de ltb4 en medicina veterinaria UY27731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10213350A DE10213350A1 (de) 2002-03-26 2002-03-26 Verwendung von LTB¶4¶Antagonisten in der Tiermedizin

Publications (1)

Publication Number Publication Date
UY27731A1 true UY27731A1 (es) 2003-10-31

Family

ID=28050833

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27731A UY27731A1 (es) 2002-03-26 2003-03-24 Utilización de antagonistas de ltb4 en medicina veterinaria

Country Status (10)

Country Link
EP (1) EP1490042A2 (es)
JP (1) JP2005529085A (es)
AR (1) AR039141A1 (es)
AU (1) AU2003212375A1 (es)
CA (1) CA2480032A1 (es)
DE (1) DE10213350A1 (es)
PE (1) PE20030947A1 (es)
TW (1) TW200407109A (es)
UY (1) UY27731A1 (es)
WO (1) WO2003080037A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110869362A (zh) 2017-05-12 2020-03-06 国立研究开发法人理化学研究所 A类gpcr结合性化合物改性体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
ZA929051B (en) * 1991-11-25 1994-05-23 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition

Also Published As

Publication number Publication date
CA2480032A1 (en) 2003-10-02
WO2003080037A2 (de) 2003-10-02
WO2003080037A3 (de) 2004-06-10
EP1490042A2 (de) 2004-12-29
AU2003212375A1 (en) 2003-10-08
TW200407109A (en) 2004-05-16
PE20030947A1 (es) 2004-01-13
DE10213350A1 (de) 2003-10-16
JP2005529085A (ja) 2005-09-29
AR039141A1 (es) 2005-02-09

Similar Documents

Publication Publication Date Title
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
MXPA05006670A (es) Administracion de capsaicinoides.
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
UA90858C2 (ru) Композиция с контролируемым высвобождением варденафила
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
AU2003220317A8 (en) Methods and drug delivery systems for the treatment of orofacial diseases
MX2011013902A (es) Tratamiento de esclerosis multiple con laquinimod.
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
NZ544645A (en) Use of calcitonin in osteoarthritis
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
NZ605469A (en) Nalbuphine-based formulations and uses thereof
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
ATE505203T1 (de) Pharmazeutische kombination aus aliskiren und valsartan
MX2023000303A (es) Coagonistas de los receptores del peptido 1 similar al glucagon (glp-1) y del polipeptido insulinotropico dependiente de glucosa (gip) adecuados para el suministro oral.
YU82503A (sh) Upotreba antagonista neuronskih natrijumovih kanala za kontrolu ektoparazita kod toplokrvnih životinja
HUP0301296A2 (hu) Flupirtin alkalmazása degeneratív ízületi fájdalom kezelésére
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
UY27731A1 (es) Utilización de antagonistas de ltb4 en medicina veterinaria
PA8624501A1 (es) Piperazinas derivadas de úrea para el tratamiento de la endometrosis
IL181161A0 (en) The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics
TW200700084A (en) Combination of sodium channel blockers and their derivatives with opioid antagonists
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
ZA200501028B (en) Administration of externally administered treatment substances to animals

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150212